Summary:
- This article discusses the emerging field of "longevity tourism," where wealthy individuals seek out experimental gene therapies and other treatments in the hopes of extending their lifespan.
- It highlights the case of Robert F. Kennedy Jr., who has been traveling to clinics in countries like Russia and Panama to receive unproven treatments, raising concerns about the safety and ethics of these practices.
- The article explores the potential risks and regulatory challenges surrounding the growing industry of longevity tourism, as well as the broader implications for the future of human health and aging.